AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
Tie-up would be one of the biggest-ever pharmaceutical deals and create the world’s fourth-largest drugmaker Business live – latest updates Britain’s biggest drugmaker, AstraZeneca, is understood to be in discussions to take over its US rival Bristol Myers Squibb in a deal that would create a near-$400bn (£300bn) pharmaceutical group. AstraZeneca, run by Pascal Soriot, its longtime chief…
We haven't written up this one. Guardian Business has the full story — the link below goes straight to it.
